Pharming Group reports preliminary 2025 revenues and announces Investor Day - Pharming (NASDAQ:PHAR)

Pharming Group reports preliminary 2025 revenues and announces Investor Day - Pharming (NASDAQ:PHAR)

Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET). Total 2025 revenues are estimated to be approximately US$376 million*, exceeding the upwardly revised guidance range of US$365 to US$375 million provided in November 2025 and re…

Rare disease drugmaker lifts 2025 sales as it readies new treatment trials

Preliminary 2025 revenue of about $376M is up 27% vs 2024, with costs held near $304-$308M. Investor Day on Feb. 3 will detail 2026 outlook.